Alzheimer’s Drug Discovery Foundation – Clinical Trial Fund
Our partnership with the Alzheimer’s Drug Discovery Foundation has been one of the most meaningful and impactful collaborations in the Foundation For A Better World’s commitment to funding novel research and clinical trials in Alzheimer’s Disease. When the ADDF approached us about their new Clinical Trial Fund, we were eager to learn more.
For the past two decades, the ADDF has been an undeniable leader in the fight against Alzheimer’s. That leadership is evidenced by the fact that approximately 20 percent of all Alzheimer’s treatments currently in clinical trials have received funding from the ADDF. Their “venture philanthropy” approach is driven by ADDF’s founding Executive Director and Chief Science Officer Dr. Howard Fillit, whose scientific vision and acumen guides every ADDF investment.
“There is a lot of promising science in our space that doesn’t qualify for support from major pharmaceutical companies. We play the critical role of taking the risk to help fund such research if it shows potential.”
As such, they have embarked on an initiative to make a difference in this fight.
The goal of the Clinical Trial Fund is to raise $100M in order to:
provide the capital needed to accelerate promising, clinical-stage science now.
ensure innovation and diversity in the drug development pipeline.
improve clinical trial design and rigor across the field.
attract additional investment needed to quickly advance projects toward FDA approval.
The Clinical Trial Fund aims to cast a wide net to find the missing pieces in Alzheimer’s research using a “multiple shots on goal” approach – exploring a wide range of possible solutions by vigorously vetting the science and providing support. The CTF will carry forward risky but promising research, which just might be the drug that saves lives.
The need for innovative, strategic philanthropic investments in clinical trials is clear. The Foundation For A Better World is thrilled to be sustaining partners of the ADDF’s Clinical Trial Fund.
